Multifunctional Drug Delivery Platforms: Bridging Smart Nanocarriers, Bioprinting, and Responsive Systems

1. Introduction to Advanced Drug Delivery Technologies

The history of drug delivery has reached a revolutionary point, which is facilitated by the convergence of nanotechnology and personalized medicine. Contemporary therapeutics are no longer dealing with dosage and systemic delivery in the traditional sense but are precision-driven, safe, and patient-profiled [1]. All these are a shift in approach from broad-based to molecular-based therapy.

Figure 1. Introduction to Advanced Drug Delivery Technologies.

Figure 1. Introduction to Advanced Drug Delivery Technologies.

One of the most important breakthroughs is the improvement of therapeutic targeting and bioavailability. Complex delivery platforms like nanoparticles, vesicles, and smart carriers are designed with ultra-spacial and temporal drug release [2]. These advanced platforms offer high drug solubility, reduce side effects, and enhance therapeutic activity, especially for complex diseases like cancer and neurological disorders.

Apart from that, nanotechnology has facilitated the development of responsive and multi-functional drug delivery systems possessing the ability to respond towards physiological signals for site-specific delivery of drugs. Liposomes, dendrimers, and polymeric nanoparticles are only a few of the systems with favorable pharmacokinetics and targeted action against conventional routes [3]. The new concept is transforming the norm of drug delivery and formulation approach.

Table 1. Introduction to Advanced Drug Delivery Technologies.

Topic	Details
Revolution in Drug Delivery	The field has shifted from traditional dosage forms to precision-based, patient-profiled therapeutics, enabled by advances in nanotechnology and personalized medicine.
Targeting & Bioavailability	New platforms like nanoparticles and smart carriers allow for ultra-specific spatial and temporal drug release, enhancing solubility and reducing side effects.
Complex Diseases Addressed	These systems are especially beneficial in treating complex conditions such as cancer and neurological disorders.
Responsive Systems	Nanotechnology has led to systems that respond to physiological signals (e.g., pH, temperature) for targeted drug release.
Types of Carriers	Includes liposomes, dendrimers, and polymeric nanoparticles with favorable pharmacokinetics and improved drug targeting compared to conventional routes.
Shift in Formulation Approach	Represents a paradigm shift from broad-based drug delivery to molecular-level, responsive systems tailored to individual patient needs.

Table 1. Introduction to Advanced Drug Delivery Technologies.

Topic	Details
Revolution in Drug Delivery	The field has shifted from traditional dosage forms to precision-based, patient-profiled therapeutics, enabled by advances in nanotechnology and personalized medicine.
Targeting & Bioavailability	New platforms like nanoparticles and smart carriers allow for ultra-specific spatial and temporal drug release, enhancing solubility and reducing side effects.
Complex Diseases Addressed	These systems are especially beneficial in treating complex conditions such as cancer and neurological disorders.
Responsive Systems	Nanotechnology has led to systems that respond to physiological signals (e.g., pH, temperature) for targeted drug release.
Types of Carriers	Includes liposomes, dendrimers, and polymeric nanoparticles with favorable pharmacokinetics and improved drug targeting compared to conventional routes.
Shift in Formulation Approach	Represents a paradigm shift from broad-based drug delivery to molecular-level, responsive systems tailored to individual patient needs.

2. Smart Nanocarriers for Precision Medicine

Smart nanocarriers are one of the foundations of precision medicine for the ability to deliver drugs at the desired sites with minimum off-target toxicities. Drug delivery systems such as liposomal, vesicular, and nanoparticles have been made available to achieve greatest targeting specificity and pharmacokinetics [4]. Such nano-scale nanocarriers are engineered biotherapetically to achieve controlled release as well as high biocompatibility, particularly well-suited to diseases with local therapeutic intervention.

Ligand-targeted liposomes employ surface engineering to specifically target and bind to cellular receptors, also facilitating drug targeting to ailing tissue. With or without stability and immune evasion issues, these systems are a highly attractive path to selective drug delivery [5]. Likewise, responsive drug release and functional targeting are made possible by four-domain modular architecture of programmable lipid nanoparticles that have shown efficacy in systemic and organ-directed delivery [6].

Table 2. Smart Nanocarriers in Precision Medicine.

Topic	Details
Foundation of Precision Medicine	Smart nanocarriers enable site-specific drug delivery with minimal off-target toxicity, forming a core part of precision medicine.
Types of Delivery Systems	Includes liposomal, vesicular, and nanoparticle-based systems designed for superior pharmacokinetics and targeting specificity.
Therapeutic Engineering	These nano-scale carriers are bioengineered for controlled release, high biocompatibility, and are ideal for localized therapy.
Ligand-Targeted Liposomes	Surface-engineered to bind cellular receptors, allowing precise targeting of diseased tissue and enhancing therapeutic selectivity.
Challenges and Benefits	While immune evasion and stability remain concerns, such systems offer a promising route for selective and effective drug delivery.
Programmable Lipid Nanoparticles	Modular, four-domain structures enable functional targeting and responsive release, proving effective for both systemic and organ-specific drug delivery.

Table 2. Smart Nanocarriers in Precision Medicine.

Topic	Details
Foundation of Precision Medicine	Smart nanocarriers enable site-specific drug delivery with minimal off-target toxicity, forming a core part of precision medicine.
Types of Delivery Systems	Includes liposomal, vesicular, and nanoparticle-based systems designed for superior pharmacokinetics and targeting specificity.
Therapeutic Engineering	These nano-scale carriers are bioengineered for controlled release, high biocompatibility, and are ideal for localized therapy.
Ligand-Targeted Liposomes	Surface-engineered to bind cellular receptors, allowing precise targeting of diseased tissue and enhancing therapeutic selectivity.
Challenges and Benefits	While immune evasion and stability remain concerns, such systems offer a promising route for selective and effective drug delivery.
Programmable Lipid Nanoparticles	Modular, four-domain structures enable functional targeting and responsive release, proving effective for both systemic and organ-specific drug delivery.

Nanotechnology application in oncology has been particularly revolutionary, enabling platforms for the controlled, targeted, and effective delivery of chemotherapeutics with reduced systemic toxicity [7]. Smart drug delivery systems are designed to take advantage of tumor microenvironments, employing stimuli-responsive routes to enhance real-time versatility and optimal drug action [8].

Lipid vesicles are still valid carriers in dermal and transdermal delivery suitable for entrapment of a wide range of actives with structural integrity in biological systems [9]. Invasomes, being another of the semipermeable vesicular carrier groups, offer pathways of increasing penetration of therapeutic drugs across the skin [10]. Alcohol and terpenes based formulation is more prone to flexibility and penetration through stratum corneum, which enhances bioavailability in transdermal [11].

Progress of current times also consists of multifunctional nanoparticles with the potential to achieve double drug release, photothermal, and photodynamic treatment. These hybrid platforms enable synergistic modalities of therapy with extremely high effectiveness in vascular tumors and widen the scope of nanomedicine towards challenging pathologies [12].

3. Transdermal and Mucosal Delivery Innovations

Microneedling technology has revolutionized mucosal and transdermal delivery with pain-free, minimally invasive delivery of vaccines and drugs. Pain-free stratum corneum penetration of the skin by the microscopic tips brings the agents into the dermis, increasing bioavailability and patient compliance [13]. The method is especially effective for large molecules and biologics hitherto bedeviled by passive skin permeability.

Second-generation microneedle systems currently comprise materials and structural designs capable of controlled release, enhanced mechanical stability, and greater therapeutic potency. Their ability to deliver a wide range of drugs — from small molecules to DNA — makes them a versatile nanomedicine platform [14].

Table 3. Microneedling Technology in Drug Delivery.

Aspect	Details
Overview	Microneedling offers a minimally invasive, pain-free method for mucosal and transdermal drug and vaccine delivery.
Mechanism of Action	Microscopic needle tips penetrate the stratum corneum to deliver drugs into the dermis, increasing bioavailability and improving patient compliance.
Advantages for Large Molecules	Particularly effective for biologics and large molecules that cannot passively permeate the skin.
Second-Generation Innovations	Comprise advanced materials and structural designs allowing controlled release, improved mechanical strength, and higher therapeutic effectiveness.
Versatility	Capable of delivering a broad spectrum of therapeutic agents, including small molecules, peptides, proteins, and nucleic acids (e.g., DNA).

Table 3. Microneedling Technology in Drug Delivery.

Aspect	Details
Overview	Microneedling offers a minimally invasive, pain-free method for mucosal and transdermal drug and vaccine delivery.
Mechanism of Action	Microscopic needle tips penetrate the stratum corneum to deliver drugs into the dermis, increasing bioavailability and improving patient compliance.
Advantages for Large Molecules	Particularly effective for biologics and large molecules that cannot passively permeate the skin.
Second-Generation Innovations	Comprise advanced materials and structural designs allowing controlled release, improved mechanical strength, and higher therapeutic effectiveness.
Versatility	Capable of delivering a broad spectrum of therapeutic agents, including small molecules, peptides, proteins, and nucleic acids (e.g., DNA).

Invasomal systems, another transdermal technology, produce long-duration therapeutic effect by skin permeation and drug retention. Permeation enhancers like ethanol and terpenes, these vesicles are designed to enable improved penetration into deeper dermis and prolonged release of drugs [15]. Mucoadhesive invasomes go a step further by targeting mucosal surfaces, providing extended residence time and local action for mucosal drug delivery processes [16].

Ultradeformable liposomes and elastic liposomes also demonstrate remarkable enhancement of the delivery of active pharmaceutical ingredients (APIs) via the skin. Due to their potential to deform and penetrate small pores without bursting, their percutaneous absorption and drug stability are enhanced [17]. Even topical formulations like skin creams have been re-optimized with nanotechnology advancements with a view to enhance their drug-loading capacity, homogeneity, and controlled release of the drug [18].

4. Biodegradable and Sustainable Systems in Drug Delivery

With greater focus on sustainability, it has developed drug delivery systems based on biodegradable and environmentally friendly materials. Besides the addition of minimizing environmental effects, they also provide biocompatible to native environments controlled release and degradative profiles [19]. Such technologies comprise renewable carriers, bioresorbable composites, and natural polymers that all fall under the philosophy of green healthcare technologies.

Green nanotechnology is also changing this sector by making the synthesis of nanoparticles using plant extracts, microorganisms, and other cells easier. Green processes involving minimal use of toxic solvents and harsh chemical conditions render the end product biocompatible and active nanomaterials as drug delivery systems [20]. These kinds of methods are also founded on the trend towards green nanomedicine.

Three-dimensional (3D) printing via the technique of fused deposition modeling (FDM) has been explored as a method of printing patient-specific drug-loaded biodegradable polymer-based implantations. FDM provides precise drug loading, release profile, and geometry, and hence patient-specific targeted therapies become achievable [21].

Likewise, stereolithography (SLA) 3D printing has shown to be viable in producing intravesical drug delivery devices within a bladder. The geometries can be fashioned to be filled with more than one drug and release over an extended period. Such geometries are therefore best suited for local and chronic treatment [22]. Overall, sustainability combined with frontier manufacturing is the new generation of green precision drug delivery.

Figure 2. xxx.

Figure 2. xxx.

5. Role of AI and Smart Systems in Drug Targeting

Artificial intelligence (AI) is increasingly being applied to drug delivery to facilitate data-driven decision-making for individual therapy, pharmacokinetic prediction, and nanoformulation optimization. AI algorithms can be employed to aid in the design of nanocarriers with tailored physicochemical properties and targeting ability, enhancing therapeutic specificity with reduced systemic side effects [23]. Such astute systems represent a significant leap towards highly responsive and dynamic platforms for therapy.

Concurrently, SORT nanoparticles are transforming tissue-targeted delivery. Organ-level biodistribution profiles are utilized by the engineered carriers to deliver the drug to a targeted site, providing maximum efficacy and reduced toxicity. The technique has proven promising in the delivery of mRNA to organs like the liver and lungs, providing maximum gene expression specificity and translational potential [24].

Along with chemical targeting, physical targeting methods like percutaneous ablation are being integrated into multimodal regimens. Image-guided such therapies enable drug-targeted alone or drug-delivery nanocarriers delivery to the tumors and lesions with superior outcomes by targeted intervention [25].

Table 4. Role of AI and Smart Systems in Drug Targeting.

Category	Description
AI in Drug Delivery	AI facilitates data-driven therapeutic decisions, predicts pharmacokinetics, and optimizes nanocarrier design for enhanced specificity and reduced side effects.
Smart Nanocarriers	AI-designed nanocarriers are tailored for precise physicochemical and targeting properties, representing dynamic and responsive delivery platforms.
SORT Nanoparticles	Engineered to exploit organ-level biodistribution for tissue-specific delivery (e.g., mRNA to liver/lungs), enhancing efficacy and minimizing systemic toxicity.
Physical Targeting Techniques	Image-guided approaches like percutaneous ablation integrate with nanomedicine for localized drug delivery to tumors and lesions.

Table 4. Role of AI and Smart Systems in Drug Targeting.

Category	Description
AI in Drug Delivery	AI facilitates data-driven therapeutic decisions, predicts pharmacokinetics, and optimizes nanocarrier design for enhanced specificity and reduced side effects.
Smart Nanocarriers	AI-designed nanocarriers are tailored for precise physicochemical and targeting properties, representing dynamic and responsive delivery platforms.
SORT Nanoparticles	Engineered to exploit organ-level biodistribution for tissue-specific delivery (e.g., mRNA to liver/lungs), enhancing efficacy and minimizing systemic toxicity.
Physical Targeting Techniques	Image-guided approaches like percutaneous ablation integrate with nanomedicine for localized drug delivery to tumors and lesions.